These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34032140)

  • 1. Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population-Based Study.
    Saadatagah S; Pasha AK; Alhalabi L; Sandhyavenu H; Farwati M; Smith CY; Wood-Wentz CM; Bailey KR; Kullo IJ
    J Am Heart Assoc; 2021 Jun; 10(11):e019343. PubMed ID: 34032140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that triglycerides are an independent coronary heart disease risk factor.
    Cullen P
    Am J Cardiol; 2000 Nov; 86(9):943-9. PubMed ID: 11053704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Johnson SL; Seeger JD; Jacobson TA
    J Clin Lipidol; 2012; 6(5):450-61. PubMed ID: 23009781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease.
    Sprecher DL; Watkins TR; Behar S; Brown WV; Rubins HB; Schaefer EJ
    Am J Cardiol; 2003 Mar; 91(5):575-80. PubMed ID: 12615263
    [No Abstract]   [Full Text] [Related]  

  • 9. Triglycerides and coronary risk.
    Gaziano JM
    Curr Cardiol Rep; 1999 Jul; 1(2):125-30. PubMed ID: 10980831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.
    Eberly LE; Stamler J; Neaton JD;
    Arch Intern Med; 2003 May; 163(9):1077-83. PubMed ID: 12742806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysis.
    Toth PP; Philip S; Hull M; Granowitz C
    Clin Cardiol; 2019 Oct; 42(10):908-913. PubMed ID: 31368589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.
    Pedersen SB; Langsted A; Nordestgaard BG
    JAMA Intern Med; 2016 Dec; 176(12):1834-1842. PubMed ID: 27820614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
    Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM
    JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of triglyceride as a coronary artery disease risk factor.
    Miller M
    Clin Cardiol; 1999 Jun; 22(6 Suppl):II1-6. PubMed ID: 10376190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
    Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglycerides and coronary risk in women and the elderly.
    LaRosa JC
    Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence.
    Miller M
    Eur Heart J; 1998 Jul; 19 Suppl H():H18-22. PubMed ID: 9717060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.